High-throughput production of functional prototissues capable of producing NO for vasodilation

Xiangxiang Zhang, Chao Li, Fukai Liu, Wei Mu, Yongshuo Ren, Boyu Yang, Xiaojun Han

TL;DR

Researchers have developed a high-throughput method to create complex, spatially programmed "prototissues" using magnetic forces. These prototissues can perform multi-step biochemical reactions and, importantly, produce nitric oxide (NO) to induce vasodilation in blood vessels, demonstrating their potential for biomedical applications.

What Problem Does This Paper Address?

Understanding the intricate cellular communication within natural tissues is crucial for developing strategies to repair or enhance damaged tissues. While "prototissues" (artificial constructs mimicking tissue components) have been created, they often lack the spatial programming and functional complexity needed for advanced applications. Existing methods for building spatially defined prototissues are typically low-throughput, limiting their scalability. Furthermore, demonstrating that prototissues can actively improve the function of living tissues, rather than just mimicking them, has been a significant challenge. This paper addresses the need for a scalable method to create sophisticated prototissues capable of complex signaling and functional output, specifically aiming to demonstrate their therapeutic potential.

Methods

The core of this work lies in a novel, high-throughput method for fabricating spatially programmable prototissues using the magneto-Archimedes effect. This technique leverages a custom device featuring a nickel mesh placed above a permanent magnet. Giant unilamellar vesicles (GUVs), acting as building blocks, are drawn to specific regions of weak magnetic field within the mesh. By controlling the magnetic field distribution (vertical vs. inclined) and the order/number of different GUVs added, the researchers can precisely dictate the spatial arrangement of components within the prototissues.

Key aspects of the methodology include:

  • Magneto-Archimedes Effect: Diamagnetic GUVs are manipulated by magnetic field gradients, allowing for controlled assembly.
  • High-Throughput Fabrication: The system can produce over 2000 prototissues in just 2 hours, a significant improvement over previous methods.
  • Spatial Programming: The ability to create two- and three-component prototissues with defined spatial arrangements is achieved by varying magnetic field configurations and GUV addition sequences.
  • Signal Communication: The prototissues are engineered to perform cascade enzyme reactions. This allows for multi-step signal processing, mimicking biological pathways. For example, glucose is converted to hydrogen peroxide (H₂O₂), which then triggers further reactions.
  • Functional Output (NO Production): A key innovation is the design of prototissues capable of producing nitric oxide (NO). This is achieved through a cascade involving glucose oxidase (GOx) and horseradish peroxidase (HRP) in the presence of glucose and hydroxyurea.
  • In Vitro Vasodilation Assay: The functional capacity of the NO-producing prototissues was tested on isolated rat blood vessels to demonstrate their ability to induce vasodilation.

Datasets

Not discussed in the paper. The study relies on the self-assembly of GUVs and the use of standard biochemical reagents.

Key Insights and Ideas

  • Scalable Spatial Control: The magneto-Archimedes effect provides an unprecedented level of control over the spatial organization of prototissue components at a high throughput, moving beyond simple random aggregation.
  • Hierarchical Signal Processing: The ability to implement two- and three-step cascade reactions within prototissues opens doors for creating more complex artificial biological systems that can process information in a sequential manner.
  • Functional Therapeutic Potential: The demonstration that these prototissues can actively induce vasodilation in living blood vessels is a critical step towards their use in treating cardiovascular diseases. This moves beyond mere mimicry to functional intervention.
  • Modular Design: The GUV-based approach allows for modularity, where different GUVs carrying specific enzymes or molecules can be combined to create diverse functionalities.

Key Results

  • High-throughput production: Over 2000 prototissues were produced within 2 hours.
  • Complex structures: Two- and three-component prototissues with defined spatial arrangements (e.g., eye structures, layered bricks) were successfully fabricated.
  • Signal communication demonstrated: Two- and three-step enzyme cascade reactions were successfully implemented within the prototissues, leading to detectable signal outputs.
  • NO production confirmed: Prototypes were engineered to produce NO upon stimulation with glucose and hydroxyurea.
  • In vitro vasodilation: NO-producing prototissues caused a significant decrease in tension force (2.59 g) and a 31.2% relaxation in rat blood vessels, comparable to a standard NO donor (SNP).

Limitations and Future Work

  • In vivo application: While the in vitro vasodilation is promising, the study does not yet demonstrate the efficacy or safety of these prototissues in living organisms.
  • Long-term stability and biocompatibility: Although prototissues showed stability for up to 18 days in vitro, further investigation into their long-term biocompatibility and degradation profiles in a biological environment is needed.
  • Complexity of biological tissues: The current prototissues are simplified models. Future work could involve incorporating a wider variety of cell types and extracellular matrix components to create even more biomimetic structures.
  • Targeted delivery: Developing methods for targeted delivery of these prototissues to specific sites within the body would be a crucial next step for therapeutic applications.

The authors suggest that this versatile methodology provides a pathway to fabricate increasingly complex programmable prototissues with significant potential in the biomedical field, particularly for treating cardiovascular diseases.

Summary updated

Abstract

Bottom-up synthesis of prototissues helps us to understand the internal cellular communications in the natural tissues and their functions, as well as to improve or repair the damaged tissues. The existed prototissues are rarely used to improve the function of living tissues. We demonstrate a methodology to produce spatially programmable prototissues based on the magneto-Archimedes effect in a high-throughput manner. More than 2000 prototissues are produced once within 2 h. Two-component and three-component spatial coded prototissues are fabricated by varying the addition giant unilamellar vesicles order/number, and the magnetic field distributions. Two-step and three-step signal communications in the prototissues are realized using cascade enzyme reactions. More importantly, the two-component prototissues capable of producing nitric oxide cause vasodilation of rat blood vessels in the presence of glucose and hydroxyurea. The tension force decreases 2.59 g, meanwhile the blood vessel relaxation is of 31.2%. Our works pave the path to fabricate complicated programmable prototissues, and hold great potential in the biomedical field.
BibTeX
@inproceedings{zhang2022high,
  author = {Xiangxiang Zhang and Chao Li and Fukai Liu and Wei Mu and Yongshuo Ren and Boyu Yang and Xiaojun Han},
  title = {{High-throughput production of functional prototissues capable of producing NO for vasodilation}},
  booktitle = {Nature Communications},
  year = {2022},
  doi = {10.1038/s41467-022-29571-3},
}
Figure